F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment
|ClinicalTrials.gov Identifier: NCT01633255|
Recruitment Status : Withdrawn
First Posted : July 4, 2012
Last Update Posted : May 17, 2018
National Cancer Institute (NCI)
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Recruitment Status :||Withdrawn|
|Actual Primary Completion Date :||April 23, 2014|
|Actual Study Completion Date :||April 23, 2014|
Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002 Mar;2(3):161-74. Review.
Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 1994 Apr 22;264(5158):569-71.